AI assistant
Sending…
Vanda Pharmaceuticals Inc. — Director's Dealing 2010
Jan 7, 2010
33390_dirs_2010-01-06_b803eda5-d6c6-4b82-861d-f2301aeb462a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2010-01-04
Reporting Person: TANG KEVIN C (10% Owner)
Reporting Person: TANG CAPITAL MANAGEMENT LLC (10% Owner)
Reporting Person: TANG CAPITAL PARTNERS LP (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-01-04 | Common Stock | S | 100000 | $11.6532 | Disposed | 2965852 | Indirect |
| 2010-01-05 | Common Stock | S | 45500 | $11.4783 | Disposed | 2920352 | Indirect |
Footnotes
F1: The securities are held by Tang Capital Partners, LP. Kevin C. Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of Tang Capital Partners, LP. Mr. Tang disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
More from Vanda Pharmaceuticals Inc.
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Board/Management Information
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 24
Regulatory Filings
2026
Feb 23
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19